EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles

Jason R Thomas, Claude Shelton, Jason Murphy, Scott Brittain, Mark-Anthony Bray, Peter Aspesi, John Concannon, Frederick J King, Robert J Ihry iD, Daniel J Ho, Martin Henault, Andrea Hadjikyriacou and 16 more

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.3c00737 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Jason R Thomas and 27 co-authors. Institution: Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States. Major MEDLINE topics: Drug Discovery, High-Throughput Screening Assays, Small Molecule Libraries. Cited 7 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Phenotypic assays have become an established approach to drug discovery. Greater disease relevance is often achieved through cellular models with increased complexity and more detailed readouts, such as gene expression or advanced imaging. However, the intricate nature and cost of these assays impose limitations on their screening capacity, often restricting screens to well-characterized small compound sets such as chemogenomics libraries. Here, we outline a cheminformatics approach to identify a small set of compounds with likely novel mechanisms of action (MoAs), expanding the MoA search space for throughput limited phenotypic assays. Our approach is based on mining existing large-scale, phenotypic high-throughput screening (HTS) data. It enables the identification of chemotypes that exhibit selectivity across multiple cell-based assays, which are characterized by persistent and broad structure activity relationships (SAR). We validate the effectiveness of our approach in broad cellular profiling assays (Cell Painting, DRUG-seq, and Promotor Signature Profiling) and chemical proteomics experiments. These experiments revealed that the compounds behave similarly to known chemogenetic libraries, but with a notable bias toward novel protein targets. To foster collaboration and advance research in this area, we have curated a public set of such compounds based on the PubChem BioAssay dataset and made it available for use by the scientific community.

Subjects

MeSH terms (MEDLINE)

Drug DiscoveryHigh-Throughput Screening AssaysSmall Molecule LibrariesCheminformaticsStructure-Activity Relationship

Substances

Small Molecule Libraries

Authors and institutions

  • Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.
  • Novartis Biomedical Research, San Diego, California 92121, United States.
  • Novartis Biomedical Research, Basel 4056, Switzerland.
  • Novartis Biomedical Research, Emeryville, California 94608, United States.

ORCID profiles: Robert J Ihry, Eric J Martin, Markus Schirle, Steffen Renner

Cite

APA

Thomas, J. R., Shelton, C., Murphy, J., Brittain, S., Bray, M. A., Aspesi, P., Concannon, J., King, F. J., Ihry, R. J., Ho, D. J., Henault, M., Hadjikyriacou, A., Neri, M., Sigoillot, F. D., Pham, H. T., Shum, M., Barys, L., Jones, M. D., Martin, E. J., …, & Renner, S. (2024). Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00737

Vancouver

Thomas JR, Shelton C, Murphy J, Brittain S, Bray MA, Aspesi P, et al. Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00737

BibTeX
@article{Thomas2024,
  author = {Thomas, Jason R and Shelton, Claude and Murphy, Jason and Brittain, Scott and Bray, Mark-Anthony and Aspesi, Peter and Concannon, John and King, Frederick J and Ihry, Robert J and Ho, Daniel J and Henault, Martin and Hadjikyriacou, Andrea and Neri, Marilisa and Sigoillot, Frederic D and Pham, Helen T and Shum, Matthew and Barys, Louise and Jones, Michael D and Martin, Eric J and Blechschmidt, Anke and Rieffel, Sébastien and Troxler, Thomas J and Mapa, Felipa A and Jenkins, Jeremy L and Jain, Rishi K and Kutchukian, Peter S and Schirle, Markus and Renner, Steffen},
  title = {Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.3c00737}
}
Start for free →